Poland to promote Biotech and pharma sector in UAE

The Polish Investment and Trade Agency along with leading Polish companies will highlight the country's Bio-Pharma offerings at the upcoming Middle East Pharma Cold Chain Congress in Dubai


Dubai, United Arab Emirates: Leading pharmaceutical and nutrition supplement manufacturing firms from Poland will highlight their offerings and expertise at the Middle East Pharma Cold Chain Congress happening next week in Dubai.

The UAE remains one of the high potential markets for Poland with trade between both countries crossing $750 million in 2018. The Polish Investment and Trade Agency, under its Sector-Promotion Programme, will participate to promote biotech and pharmaceutical services at the Congress with four major companies including Global Pharma, Gofarm, Exim Pharma, and Z.F. Unia exhibiting at the event.

“Poland is well known as the supplier of raw materials for the pharma and nutrition manufacturers in the UAE. We are also pleased to see growing interest from Polish manufacturers to expand into the UAE, which is also known as the strategic hub for cooperation with the GCC. This is especially interesting considering EXPO 2020 in Dubai, where Poland is participating. Poland’s participation is organised by Polish Investment and Trade Agency.” – explains Moneer Faour, Head of Polish Foreign Trade Office in Dubai.

The upcoming congress is another event in the medical and healthcare sector in the UAE in recent weeks, which sees the participation of Polish companies. Middle East Pharma Cold Chain Congress will be held on March 19-21 in Millenium Airport Hotel, Dubai.

The Middle East Pharma Cold Chain Congress is organised by Maarefah Management and supported by the Saudi Pharmaceutical Society. It is sponsored by leading pharmaceutical companies including Global Pharma, LisaLine, Zakłady Farmaceutyczne UNIA Spółdzielnia Pracy, Technical Supplies & Services Co.L.L.C and Polish Investment and Trade Agency.

Source: Polish Investment and Trade Agency.

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases